10/30/2024
8:45 PM | Blok Tyler (Reporting)
CytoDyn (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
8:45 PM | Brunke Karen J (Reporting)
CytoDyn (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
8:46 PM | CytoDyn (Issuer)
Dunlap Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
8:47 PM | CytoDyn (Issuer)
Lalezari Jacob P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
8:47 PM | CytoDyn (Issuer)
Ndhlovu Lishomwa C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
8:48 PM | CytoDyn (Issuer)
SIMES STEPHEN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
8:48 PM | CytoDyn (Issuer)
Urbach Tanya Durkee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/17/2024
4:15 PM | CytoDyn (Filer)
| Form 424B3 | |
10/15/2024
4:16 PM | CytoDyn (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/11/2024
8:00 AM | CytoDyn (Filer)
| Form DEF 14A | |
10/01/2024
11:15 PM | CytoDyn (Filer)
| Form EFFECT | |
10/01/2024
4:15 PM | CytoDyn (Filer)
| Form 424B3 | |
09/30/2024
4:01 PM | CytoDyn (Filer)
| Form 10-K/A | |
09/12/2024
11:15 PM | CytoDyn (Filer)
| Form EFFECT | |
09/12/2024
11:15 PM | CytoDyn (Filer)
| Form EFFECT | |
09/06/2024
7:42 PM | CytoDyn (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/06/2024
7:44 PM | CytoDyn (Filer)
| Form POS AM | |
09/06/2024
7:44 PM | CytoDyn (Filer)
| Form POS AM | |
08/15/2024
4:21 PM | CytoDyn (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
07/22/2024
8:00 AM | CytoDyn (Subject)
| Form SC TO-I/A | |
07/09/2024
4:16 PM | CytoDyn (Subject)
| Form SC TO-I/A | |
07/09/2024
4:16 PM | CytoDyn (Filer)
| Form 424B3 | |
07/09/2024
4:17 PM | CytoDyn (Filer)
| Form 424B3 | |
07/09/2024
7:46 AM | CytoDyn (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
4:11 PM | CytoDyn (Subject)
| Form SC TO-I/A | |
06/20/2024
2:16 PM | CytoDyn (Subject)
| Form SC TO-I/A | |
06/03/2024
4:15 PM | CytoDyn (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
4:17 PM | CytoDyn (Filer)
| Form 424B3 | |
04/16/2024
4:15 PM | CytoDyn (Filer)
| Form 424B3 | |
04/16/2024
4:16 PM | CytoDyn (Filer)
| Form 424B3 | |
04/15/2024
4:18 PM | CytoDyn (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/08/2024
4:16 PM | CytoDyn (Filer)
| Form 424B3 | |
04/08/2024
4:17 PM | CytoDyn (Filer)
| Form 424B3 | |
04/08/2024
7:31 AM | CytoDyn (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
4:16 PM | CytoDyn (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
8:30 PM | CytoDyn (Issuer)
Lalezari Jacob P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:15 PM | CytoDyn (Filer)
| Form 424B3 | |
03/01/2024
4:16 PM | CytoDyn (Filer)
| Form 424B3 | |
02/22/2024
4:16 PM | CytoDyn (Filer)
| Form 424B3 | |
02/21/2024
11:15 PM | CytoDyn (Filer)
| Form EFFECT | |
02/15/2024
8:00 PM | COHEN MITCHELL (Reporting)
CytoDyn (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
This company will win the AI race (Ad) Rome wasn’t built in a day…
But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence.
And without it, the entire AI industry would collapse.  You must read this new presentation from Porter Stansberry. |
02/12/2024
4:31 PM | CytoDyn (Subject)
Welch David F (Filed by)
| Form SC 13G/A | |
02/06/2024
8:32 PM | CytoDyn (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/29/2024
7:40 AM | CytoDyn (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
4:15 PM | CytoDyn (Filer)
| Form 424B3 | |
01/16/2024
4:16 PM | CytoDyn (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/05/2024
8:01 PM | Blok Tyler (Reporting)
CytoDyn (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
8:01 PM | Brunke Karen J (Reporting)
CytoDyn (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
8:02 PM | CytoDyn (Issuer)
Dunlap Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
8:02 PM | CytoDyn (Issuer)
Ndhlovu Lishomwa C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
8:03 PM | CytoDyn (Issuer)
SIMES STEPHEN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
8:04 PM | CytoDyn (Issuer)
Urbach Tanya Durkee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
8:04 PM | CytoDyn (Issuer)
Migliarese Antonio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:15 PM | CytoDyn (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
7:30 AM | CytoDyn (Filer)
| Form 424B3 | |
12/14/2023
4:22 PM | CytoDyn (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
4:16 PM | CytoDyn (Issuer)
Lalezari Jacob P (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/22/2023
11:16 AM | CytoDyn (Filer)
| Form 424B3 | |
11/21/2023
4:15 PM | CytoDyn (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
